Ozturk E, Aslan Cin N, Cansu A, Akyol A
Metab Brain Dis. 2024; 40(1):67.
PMID: 39692905
DOI: 10.1007/s11011-024-01506-5.
Guerreiro D, Almeida A, Ramalho R
Nutrients. 2024; 16(23).
PMID: 39683388
PMC: 11643373.
DOI: 10.3390/nu16233994.
Abdel-Rahman M, Hussein A, Ahmed-Farid O, Sawi A, Abdel Moneim A
Metab Brain Dis. 2024; 39(7):1291-1305.
PMID: 39292431
PMC: 11513736.
DOI: 10.1007/s11011-024-01415-7.
He F, Ye L, Wang L, Zhou J, Shao X, Miao P
CNS Neurosci Ther. 2024; 30(7):e14854.
PMID: 39021297
PMC: 11255014.
DOI: 10.1111/cns.14854.
Li B, Ma Y, Wang X, Zhao D, Wang Z, Wang G
Neurochem Res. 2024; 49(10):2726-2742.
PMID: 38935224
DOI: 10.1007/s11064-024-04168-y.
β-hydroxybutyrate resensitizes colorectal cancer cells to oxaliplatin by suppressing H3K79 methylation in vitro and in vivo.
Deng M, Yan P, Gong H, Li G, Wang J
Mol Med. 2024; 30(1):95.
PMID: 38910244
PMC: 11194918.
DOI: 10.1186/s10020-024-00864-1.
ADCY3: the pivotal gene in classical ketogenic diet for the treatment of epilepsy.
Lin M, Gong J, Wu L, Lin X, Zhang Y, Lin W
Front Cell Neurosci. 2024; 18:1305867.
PMID: 38841200
PMC: 11150708.
DOI: 10.3389/fncel.2024.1305867.
Ketogenic Diet in the Treatment of Epilepsy.
Borowicz-Reutt K, Krawczyk M, Czernia J
Nutrients. 2024; 16(9).
PMID: 38732505
PMC: 11085120.
DOI: 10.3390/nu16091258.
Role of liver FGF21-KLB signaling in ketogenic diet-induced amelioration of hepatic steatosis.
Guo W, Cao H, Shen Y, Li W, Wang W, Cheng L
Nutr Diabetes. 2024; 14(1):18.
PMID: 38609395
PMC: 11014968.
DOI: 10.1038/s41387-024-00277-3.
Exploring the impacts of ketogenic diet on reversible hepatic steatosis: initial analysis in male mice.
Ravaut G, Carneiro A, Mounier C
Front Nutr. 2024; 11:1290540.
PMID: 38577162
PMC: 10991688.
DOI: 10.3389/fnut.2024.1290540.
Ketogenic therapy towards precision medicine for brain diseases.
Liu Y, Fan L, Yang H, Wang D, Liu R, Shan T
Front Nutr. 2024; 11:1266690.
PMID: 38450235
PMC: 10915067.
DOI: 10.3389/fnut.2024.1266690.
Hypocarnitinemia and its effect on seizure control in adult patients with intractable epilepsy on the modified Atkins diet.
Chu D, Ravelli M, Faltersack K, Woods A, Almane D, Li Z
Front Nutr. 2024; 10:1304209.
PMID: 38249600
PMC: 10796679.
DOI: 10.3389/fnut.2023.1304209.
Pathophysiology to Risk Factor and Therapeutics to Treatment Strategies on Epilepsy.
de Araujo Boleti A, Cardoso P, Frihling B, de Moraes L, Nunes E, Mukoyama L
Brain Sci. 2024; 14(1).
PMID: 38248286
PMC: 10813806.
DOI: 10.3390/brainsci14010071.
Ketogenic Diet and Breast Cancer: Recent Findings and Therapeutic Approaches.
Urzi A, Tropea E, Gattuso G, Spoto G, Marsala G, Calina D
Nutrients. 2023; 15(20).
PMID: 37892432
PMC: 10609494.
DOI: 10.3390/nu15204357.
Obesity control and liver health in breast cancer: Normalized hepatic elasticity after ketogenic diet.
Georgiev A, Chervenkov L, Koleva D, Anastasova V
Heliyon. 2023; 9(10):e20449.
PMID: 37780747
PMC: 10539953.
DOI: 10.1016/j.heliyon.2023.e20449.
Nutritional Intervention Through Ketogenic Diet in GLUT1 Deficiency Syndrome.
Kim Y, Kim W, Na J, Lee Y
Clin Nutr Res. 2023; 12(3):169-176.
PMID: 37593212
PMC: 10432162.
DOI: 10.7762/cnr.2023.12.3.169.
Ketogenic Diet and Ketone Bodies as Clinical Support for the Treatment of SARS-CoV-2-Review of the Evidence.
Boleslawska I, Kowalowka M, Boleslawska-Krol N, Przyslawski J
Viruses. 2023; 15(6).
PMID: 37376562
PMC: 10326824.
DOI: 10.3390/v15061262.
A neuron-specific Isca1 knockout rat developments multiple mitochondrial dysfunction syndromes.
Sheng H, Lu D, Qi X, Ling Y, Li J, Zhang X
Animal Model Exp Med. 2023; 6(2):155-167.
PMID: 37140997
PMC: 10158949.
DOI: 10.1002/ame2.12318.
Metabolic Effects of Ketogenic Diets and Their Utilization in Obesity Management: A Systematic Review.
Malhotra V, Sawal A
Cureus. 2023; 15(3):e36720.
PMID: 37123756
PMC: 10130479.
DOI: 10.7759/cureus.36720.
The Diet as a Modulator of Tumor Microenvironment in Colorectal Cancer Patients.
Collado M, Castillo M, Munoz de Mier G, De la Pinta C, Pena C
Int J Mol Sci. 2023; 24(8).
PMID: 37108477
PMC: 10139215.
DOI: 10.3390/ijms24087317.